Pearl River Capital’s Boston Scientific BSX Stock Holding History

Pearl River Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,195	Closed	-$443K	–	499
2023 Q2	$443K	Buy	+8,195	New	+$428K	0.07%	337
2022 Q2	–	Sell	-24,653	Closed	-$1.09M	–	449
2022 Q1	$1.09M	Buy	+24,653	New	+$1.07M	0.3%	101
2021 Q1	–	Sell	-26,466	Closed	-$951K	–	399
2020 Q4	$951K	Buy	+26,466	New	+$954K	0.34%	100
2019 Q4	–	Sell	-6,280	Closed	-$256K	–	532
2019 Q3	$256K	Buy	+6,280	New	+$266K	0.73%	3
2019 Q2	–	Sell	-4,400	Closed	-$168K	–	289
2019 Q1	$168K	Buy	+4,400	New	+$168K	0.42%	111

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pearl River Capital's BSX Position: Q3 2023 in Review

Pearl River Capital sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 8,195 shares — an estimated $443K sold.

Pearl River Capital first reported a position in BSX in Q1 2019 and held it in 5 quarters. The position peaked at $1.09M in Q1 2022. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

Pearl River Capital reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
Pearl River Capital sold 8,195 Boston Scientific shares in Q3 2023, an estimated $443K.
Pearl River Capital first reported a position in Boston Scientific in Q1 2019 and held it in 5 quarters.
Pearl River Capital's Boston Scientific position peaked at $1.09M in Q1 2022.
1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Pearl River Capital's 13F filing for Q3 2023, filed 13 Nov 2023.